文献速递消化道肿瘤与早癌消化内镜

无症状成人进展期结直肠肿瘤预测模型的推导与验证

Derivation and validation of a predictive model for advanced colorectal neoplasia in asymptomatic adults.
PubMed 文献 · Gut · 2020-09-29

在印第安纳州内镜中心招募50至80岁平均风险首次筛查结肠镜受试者,测量社会人口学、体格、病史、家族史和生活方式因素并与最晚期发现关联。在三分之二样本推导13变量模型并赋分,在剩余样本验证。模型区分度高,可识别低风险亚组(可考虑非侵入性筛查)和高风险亚组(可能首选结肠镜)。

要点

  • 推导集3025人,进展期结直肠肿瘤患病率9.4%,13变量模型c统计量0.77。
  • 验证集1475人,患病率8.4%,模型c统计量0.78,区分度与推导集相当。
  • 模型将人群分为低、中、高风险三组,高风险组进展期结直肠肿瘤风险约25%至27%。

核心结论

  • 在平均风险人群中,该模型以高区分度估计进展期结直肠肿瘤风险。
  • 模型识别出可考虑非侵入性筛查的低风险亚组和可能首选结肠镜的高风险亚组。
  • 模型可能有助于指导医患筛查选择讨论,可能提高筛查依从性并节约结肠镜资源。

研究设计与样本

  • 在印第安纳州内镜中心招募50至80岁平均风险首次筛查结肠镜受试者。
  • 测量社会人口学与体格特征、病史与家族史及生活方式因素,并与最晚期发现关联。
  • 在三分之二样本推导风险方程,对每个变量赋分创建风险评分,将风险相当的评分合并为风险类别。
  • 模型与评分在剩余样本中测试。

主要发现

  • 推导集3025人(平均年龄57.3(6.5)岁;52%为女性),进展期结直肠肿瘤患病率9.4%。
  • 13变量模型c统计量0.77,低、中、高风险组进展期结直肠肿瘤风险分别为1.5%(95%CI 0.72%至2.74%)、7.06%(CI 5.89%至8.38%)和27.26%(CI 23.47%至31.30%),p值<0.001,三组分别占23%、59%和18%。
  • 验证集1475人(进展期结直肠肿瘤患病率8.4%),模型性能相当(c统计量0.78),低、中、高风险亚组进展期结直肠肿瘤风险分别为2.73%(CI 1.25%至5.11%)、5.57%(CI 4.12%至7.34%)和25.79%(CI 20.51%至31.66%),p<0.001,三组分别占23%、59%和18%。

关键数值与推荐

  • 13变量模型在推导集c统计量0.77,在验证集c统计量0.78。
  • 推导集低、中、高风险组进展期结直肠肿瘤风险分别为1.5%、7.06%和27.26%(p<0.001)。
  • 验证集低、中、高风险亚组进展期结直肠肿瘤风险分别为2.73%、5.57%和25.79%(p<0.001)。
  • 推导集与验证集低、中、高风险组占比均为23%、59%和18%。

临床怎么用

  • 原文结论指出,该模型识别出可考虑非侵入性筛查的低风险亚组和可能首选结肠镜的高风险亚组。
  • 原文结论指出,该模型可能有助于指导医患筛查选择讨论、可能提高筛查依从性并节约结肠镜资源。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Knowing risk for advanced colorectal neoplasia (AN) could help patients and providers choose among screening tests, improving screening efficiency and uptake. We created a risk prediction model for AN to help decide which test might be preferred, a use not considered for existing models. DESIGN: Average-risk 50-to-80-year olds undergoing first-time screening colonoscopy were recruited from endoscopy units in Indiana. We measured sociodemographic and physical features, medical and family history and lifestyle factors and linked these to the most advanced finding. We derived a risk equation on two-thirds of the sample and assigned points to each variable to create a risk score. Scores with comparable risks were collapsed into risk categories. The model and score were tested on the remaining sample. RESULTS: Among 3025 subjects in the derivation set (mean age 57.3 (6.5) years; 52% women), AN prevalence was 9.4%. The 13-variable model (c-statistic=0.77) produced three risk groups with AN risks of 1.5% (95% CI 0.72% to 2.74%), 7.06% (CI 5.89% to 8.38%) and 27.26% (CI 23.47% to 31.30%) in low-risk, intermediate-risk and high-risk groups (p value <0.001), containing 23%, 59% and 18% of subjects, respectively. In the validation set of 1475 subjects (AN prevalence of 8.4%), model performance was comparable (c-statistic=0.78), with AN risks of 2.73% (CI 1.25% to 5.11%), 5.57% (CI 4.12% to 7.34%) and 25.79% (CI 20.51% to 31.66%) in low-risk, intermediate-risk and high-risk subgroups, respectively (p<0.001), containing proportions of 23%, 59% and 18%. CONCLUSION: Among average-risk persons, this model estimates AN risk with high discrimination, identifying a lower risk subgroup that may be screened non-invasively and a higher risk subgroup for which colonoscopy may be preferred. The model could help guide patient-provider discussions of screening options, may increase screening adherence and conserve colonoscopy resources.

来源:Gut,查看原文。版权归原作者所有。

引用

  1. Imperiale TF, Monahan PO, Stump TE, et al. Derivation and validation of a predictive model for advanced colorectal neoplasia in asymptomatic adults. Gut. 2020. PMID: 32994311. doi:10.1136/gutjnl-2020-321698

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。